Its role Investor / Financier
Thia Ventures is an early-stage venture capital firm that invests at the intersection of food technology, biotechnology, and health. It focuses on backing startups developing sustainable, science-based solutions in precision fermentation, cultivated proteins, enzyme engineering, natural colorants, biofertilizers, and related agritech and foodtech platforms.
Established around 2021-2022 and headquartered in Singapore, the firm is managed by Eightstone Pte. Ltd., a Monetary Authority of Singapore-licensed Capital Markets Services fund manager. Thia Ventures typically participates in pre-seed through Series B rounds with check sizes from approximately $100,000 to $5 million, emphasizing technologies that are scalable, sustainable, and supported by strong industrial networks in food, biotech, and health sectors.
The portfolio includes EvodiaBio (precision fermentation for natural flavors and aromas, as noted in the provided context), Allozymes (enzyme engineering), Chromologics (natural colorants via fermentation), Clever Carnivore (cultivated beef), Protealis (climate-resilient crops), Switch Bioworks (biofertilizers), and others such as Pow.bio and uFraction8. Investments span Europe, Asia, and additional markets, supporting the shift toward bio-based and sustainable production methods.
Thia Ventures positions itself as a specialized early-stage investor contributing to innovation in the food and biotech industries, with a mission-driven approach to scalable technologies that address global challenges in nutrition, sustainability, and health.
chemXplore tracks 1 project involving Thia Ventures.
The investment will fund commercialization and expansion of a sustainable aroma technology for improving non-alcoholic beer taste, reducing resource use, and lowering CO2 emissions.
active all projects